Q1 2026 Revenue 49.8B KRW, Net Income 481.6M KRW
GC메디아이
032620
Signal Score
Historical Avg Return (5d)
-0.18%
Data Coverage
100%n=3385
Risk-adjusted indicator based on 3385 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • Q1 2026 Consolidated Revenue: 49.84 billion KRW
- • Q1 2026 Consolidated Operating Profit: 2.24 billion KRW
- • Q1 2026 Consolidated Net Income: 481.65 million KRW
- • Q1 2026 Debt-to-Equity Ratio: 45.74% (vs. 43.31% prior year-end)
- • R&D Expense to Revenue Ratio: 10.62%
AI Analysis Summary
UBCARE CO., LTD. reported Q1 2026 consolidated revenue of 49.84 billion KRW, operating profit of 2.24 billion KRW, and net income of 481.65 million KRW. The company's debt-to-equity ratio increased slightly to 45.74% from 43.31% at the end of the previous year. Research and development expenses accounted for 10.62% of revenue, indicating continued investment in innovation. The company maintains a strong market share in the EMR sector and is expanding its platform business with 'Tokdak' and 'Dr. Vice'. While revenue is stable, the net income is relatively low compared to operating profit, suggesting other expenses or financial costs impacted profitability. The report provides a detailed breakdown of business segments, with Commerce being the largest contributor at 44.9% of revenue, followed by Medical Infra at 37.2%.
How This Event Is Evaluated
Earnings Evaluation
Earnings events are evaluated by comparing profitability, growth, margin direction, and one-off factors against market expectations.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Revenue and profit growth
- Operating margin direction
- Net income quality
- One-off gains or losses
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.